XR-835
Chemical Name: (4R,5S,6S,7R)-4,7-Dibenzyl-5,6-dihydroxy-1,3-bis(1H-indazol-5-ylmethyl)perhydro-1,3-diazepin-2-one
CAS No. 167825-84-5
项目整合开发状态: Preclinical
项目研究机构: Bristol-Myers Squibb (Originator)
合成路线:The reduction of indazole-5-carboxylic acid (I) with diisobutylaluminum hydride (DIBAL) in dichloromethane gives the expected methanol (II),which by reaction with mesyl chloride and ethyldiisopropylamine in DMF is converted into 5-(chloromethyl)indazole (III).Finally,this compound is condensed with (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxyperhydro-1,3-diazepin-2-one (IV) by means of NaH in DMF.
合成路线:The radical bromination of 5-methylidazole (V) by means of N-bromosuccinimide (NBS) and benzoyl peroxide in refluxing CCl4 gives the corresponding bromomethyl derivative (VI),which is then condensed with the diazepine (IV) as before.
📌 参考资料/链接:
参考文献标题:Potent cyclic urea HIV protease inhibitors with benzofused heterocycles as P2/P2' groups
文献作者:Wang,H.; Johnson,B.L.; Rodgers,J.D.; et al.
参考来源:Bioorg Med Chem Lett 1996,6(24),2919